Sientra, Inc.
Formerly Juliet Medical, Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Mar 2012 | $65 M | No. 1 | $50 to $250 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Sientra, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2012).
SEC Form D · Jun 2012
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jun 2012
That is all the official record says: Sientra, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
In its own words
How the company describes itself to search engines on its website, word for word.
“Discover a new level of confidence with implants designed for natural softness, lasting shape, and trusted safety.”
Source: The company's website · as of Nov 15, 2026
Products and services#
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Investors#
No investor of Sientra, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 12 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Hani Zeini | Executive officer | Jun 2012 |
| Joel Smith | Executive officer | Jun 2012 |
| Matthew Pigeon | Executive officer | Jun 2012 |
| Hani Zeini | Director | Jun 2012 |
| Michele Park | Director | Jun 2012 |
| Nick Simon | Director | Jun 2012 |
| Rishi Gupta | Director | Jun 2012 |
| Robert Adelman | Director | Jun 2012 |
About
Company in Santa Barbara, United States.